Ryan Specialty Ownership
| RYAN Stock | USD 74.59 1.06 1.44% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Ryan |
Ryan Stock Ownership Analysis
About 15.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.28. Ryan Specialty Group last dividend was issued on the 12th of November 2024. Ryan Specialty Group Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. The company was founded in 2010 and is headquartered in Chicago, Illinois. Ryan Specialty operates under InsuranceSpecialty classification in the United States and is traded on New York Stock Exchange. It employs 3690 people. To find out more about Ryan Specialty Group contact Patrick Ryan at 312 784 6001 or learn more at https://www.ryanspecialty.com/.Besides selling stocks to institutional investors, Ryan Specialty also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Ryan Specialty's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Ryan Specialty's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Ryan Specialty Quarterly Liabilities And Stockholders Equity |
|
Ryan Specialty Insider Trades History
About 15.0% of Ryan Specialty Group are currently held by insiders. Unlike Ryan Specialty's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Ryan Specialty's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Ryan Specialty's insider trades
Ryan Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Ryan Specialty is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ryan Specialty Group backward and forwards among themselves. Ryan Specialty's institutional investor refers to the entity that pools money to purchase Ryan Specialty's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2 M | Geode Capital Management, Llc | 2024-09-30 | 1.8 M | Barclays Plc | 2024-06-30 | 1.6 M | Stephens Inv Mgmt Group Llc | 2024-09-30 | 1.6 M | Alliancebernstein L.p. | 2024-06-30 | 1.6 M | Polar Capital Holdings Plc | 2024-06-30 | 1.5 M | Sumitomo Mitsui Trust Group Inc | 2024-09-30 | 1.2 M | Ameriprise Financial Inc | 2024-06-30 | 1.2 M | American Century Companies Inc | 2024-09-30 | 1.1 M | Blackrock Inc | 2024-06-30 | 11.3 M | Vanguard Group Inc | 2024-09-30 | 9.4 M |
Ryan Specialty Group Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ryan Specialty insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ryan Specialty's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ryan Specialty insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ryan Specialty Outstanding Bonds
Ryan Specialty issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ryan Specialty Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ryan bonds can be classified according to their maturity, which is the date when Ryan Specialty Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US78351MAA09 Corp BondUS78351MAA09 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| US78355HKP37 Corp BondUS78355HKP37 | View | |
| US78355HKQ10 Corp BondUS78355HKQ10 | View | |
| US78355HKR92 Corp BondUS78355HKR92 | View | |
| R 175 01 SEP 26 Corp BondUS78355HKS75 | View | |
| R 285 01 MAR 27 Corp BondUS78355HKT58 | View |
Ryan Specialty Corporate Filings
13A | 13th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 12th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 31st of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 30th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Pair Trading with Ryan Specialty
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ryan Specialty position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ryan Specialty will appreciate offsetting losses from the drop in the long position's value.Moving together with Ryan Stock
| 0.78 | AGO | Assured Guaranty | PairCorr |
| 0.81 | AXS | AXIS Capital Holdings | PairCorr |
| 0.63 | EIG | Employers Holdings | PairCorr |
Moving against Ryan Stock
| 0.49 | JRVR | James River Group | PairCorr |
| 0.45 | ESNT | Essent Group | PairCorr |
| 0.39 | RDN | Radian Group | PairCorr |
| 0.38 | NMIH | NMI Holdings Normal Trading | PairCorr |
The ability to find closely correlated positions to Ryan Specialty could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ryan Specialty when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ryan Specialty - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ryan Specialty Group to buy it.
The correlation of Ryan Specialty is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ryan Specialty moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ryan Specialty Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ryan Specialty can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryan Specialty Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ryan Specialty. If investors know Ryan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ryan Specialty listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.408 | Dividend Share 0.33 | Earnings Share 0.77 | Revenue Per Share 19.549 | Quarterly Revenue Growth 0.207 |
The market value of Ryan Specialty Group is measured differently than its book value, which is the value of Ryan that is recorded on the company's balance sheet. Investors also form their own opinion of Ryan Specialty's value that differs from its market value or its book value, called intrinsic value, which is Ryan Specialty's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ryan Specialty's market value can be influenced by many factors that don't directly affect Ryan Specialty's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ryan Specialty's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ryan Specialty is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ryan Specialty's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.